# Verility, Inc.

> Verility is a small Indiana animal-health company building Fertile-Eyez, a smartphone-enabled fertility platform that uses optical hardware and AI image analysis to help livestock producers assess sperm and detect ovulation at the point of care. Its commercial wedge is swine breeding: replace some repeated heat checks, semen doses and guesswork with a direct biological signal, then turn each test into data that can improve breeding decisions.

- **Founded:** 2021
- **Headquarters:** Maxwell, Indiana, United States
- **Founders:** Liane Hart (CEO & Co-Founder), Hadi Shafiee (Inventor, Co-Founder & Technical Advisor)
- **Team size:** 4 employees listed on LinkedIn; a 2026 event profile lists 6
- **Products:** Fertile-Eyez semen analysis, Fertile-Eyez ovulation detection, Fertility analytics platform
- **Notable:** Validated smartphone-based boar semen concentration, motility and morphology against established methods in a peer-reviewed study., Reported comparable pregnancy and embryo rates in a 400-sow field study while using fewer semen doses and less labor., Reported a 91% overall conception rate and 1.6 ROI in the 2024 sow study.

## Products & services

- **Fertile-Eyez semen analysis** — A portable smartphone-based device using optical hardware and AI image analysis to assess sperm concentration, motility and morphology at the point of care.
- **Fertile-Eyez ovulation detection** — A non-invasive, mobile test designed to classify ovulation timing so swine producers can decide which animals to inseminate and when.
- **Fertility analytics platform** — A data layer intended to aggregate fertility observations and support repeatable breeding decisions across livestock operations.

## Achievements

- Validated smartphone-based boar semen concentration, motility and morphology against established methods in a peer-reviewed study.
- Reported comparable pregnancy and embryo rates in a 400-sow field study while using fewer semen doses and less labor.
- Reported a 91% overall conception rate and 1.6 ROI in the 2024 sow study.
- Won a $100,000 Purdue Ag-Celerator award in 2022.
- Closed an announced $3.5 million Series A in 2022 and completed a $4 million cumulative round by 2025.
- Built an issued patent portfolio across the United States, Canada, Europe and Australia through exclusive licenses.
- Named a Top 10 semifinalist in the 2026 Farm Bureau Ag Innovation Challenge.
- Named a finalist for the 2026 AgriNovus Indiana Agbioscience Innovation Award.

## Latest updates

- **2025-03** — Purdue published results from Verility’s 400-sow study, including 91% conception, 40% fewer semen doses, 24% less labor and a reported 1.6 ROI.
- **2025-08** — Verility was selected among the Top 10 semifinalists in the 2026 Farm Bureau Ag Innovation Challenge.
- **2025-12** — TechPoint named Verility a finalist for the 2026 AgriNovus Indiana Agbioscience Innovation Award.
- **2026-03** — An SEC Form D disclosed $150,000 sold through convertible notes in a planned $2 million offering.
- **2026-05** — Industry coverage described early field applications in which precise timing allowed single-insemination protocols to compete with two- or three-dose routines; outcomes were explicitly said to vary.

## Links

- Website: https://www.verilityco.com/
- LinkedIn: https://www.linkedin.com/company/verility-inc

---

Profile page: https://yespress.io/verility-inc
Published by YesPress — https://yespress.io
Last updated: 2026-08-21